Acquired by PMC International in December of 2017, PMC Isochem offers custom manufacturing (CDMO) and catalogue products. Our primary market is the manufacture of cGMP intermediates, active pharmaceutical ingredients (API) and excipients for pharmaceutical and personnal care companies worldwide. Our business comprises research, product/process development, regulatory approvals, pilot scale and plant-scale production
PMC Isochem mission is to add value to the intellectual property of our clients by constant innovation.
We innovate with new manufacturing techniques for sophisticated chemical intermediates, active ingredients and excipients.
We innovate throughout the whole life cycle, from the development, through the commercial launch up to the generic stage.
We commit to deliver value to our clients through the complete understanding of the customer’s key expectations. It enables us to build step by step a close and win/win relationship.
We strive to build strong long term relationships with our employees based on trust, respect and engagement, improving skills and expertise.
We dedicate ourselves to the sustainability of our operations by fully integrating our locations in their local communities in complete transparency of open communication with environment agencies, authorities and neighbours alike.
Protecting Human Safety and Health
Ethical Business Conduct
Gender Equality Index PMC Isochem 2021
The 4 indicators are :
- Gender pay gap ; maximum score 40 => Scor Index 35
- Gap in distribution of personal pay rise ; maximum score 35 => Scor Index 35
- % of female employees given a pay rise on returning from maternity leave ; maximum score 15 => Scor Index 15
- Number of women in the top ten highest paid employees ; maximum score 10 => Scor Index 5